Health Sciences and Minimal Risk IRBs, IRB News / Volume 7, Number 3, March 2015
The HS-IRBs office has recently received a large number of changes submitted for expedited review that in fact required full IRB review. Here are a few things to keep in mind when considering whether to submit a change for expedited or full review:
you are unsure whether a change may qualify for expedited review, please
contact the HS-IRBs office for assistance.
Over the coming weeks, significant changes will be made to the multisite research resources on the HS-IRBs website. These changes are being made to reflect the growing number of IRB reliance agreements in which the HS-IRBs participate as well as updated resources regarding all aspects of IRB reliance. Part of this change will be renaming the main multisite research page, which will soon be called IRB Reliance Basics. This name change is occurring to keep the HS-IRBs website in step with national trends regarding how agreements among IRBs are described. More information about these changes will be forthcoming in the April newsletter and a future workshop. If you have questions about these changes or any IRB reliance issues, please contact the HS-IRBs Reliance Team (email@example.com).
Principal Investigator Changes and Personnel Updates Guidance has been revised for clarity only (no major revisions were made) and has been posted.
If an adverse event occurs on a non-VA study and the study team needs to determine if the event requires reporting to the IRB please first consult our unanticipated problem/adverse event decision tree. Also keep in mind the general principle that if an adverse event is probably related to study participation and unexpected in any way, it most likely requires reporting to the IRB. If you need further assistance in determining whether an event requires reporting to the IRB, please contact Jessie Johnson or Emily Jenner. Note: Reporting requirements for VA studies are more stringent than those for non-VA studies. Please see the HS-IRBs Reporting and Submission Timeframes for more information about VA reporting requirements.
Apple recently launched its ResearchKit platform, designed to assist researchers with data collection, subject recruitment, and diagnostics. Since UW-Madison’s human research protection program has not yet had the opportunity to review ResearchKit in detail, study teams should not plan on using it for studies approved by a UW-Madison IRB at this time. Updates about the use of ResearchKit will be provided in future newsletters.
Whether you have a question about a specific protocol, a general question about the submission process, or need clarification about research policy, we have several ways you can reach us.